[#DIV28SUPER] 2019 Annual Vermont Center on Behavior & Health National Conference

PLEASE FORWARD BELOW AND ATTACHED:

7th Vermont Center on Behavior and Health Annual Conference

COMPLIMENTARY CONTRIBUTIONS OF TOBACCO CONTROL & REGULATORY SCIENCE RESEARCH

October 10-11, 2019

Burlington Hilton Hotel, Burlington, Vermont

The 7th Annual VCBH Conference will focus on the intersection between tobacco regulatory science and tobacco control, two of the major fields in tobacco research. We will bring together renowned researchers in both fields to see how each may compliment one another to decrease tobacco use nationwide.

 

This year's keynote speaker is Dorothy Hatsukami, Ph.D., Forster Family Chair in Cancer Prevention at the Masonic Cancer Center and Professor of Psychiatry at the University of Minnesota. Dr. Hatsukami's areas of expertise include nicotine addiction and its treatment, including testing medications such as nicotine vaccine and combination medications, in smokers.

 

We are also announcing the call for poster abstracts focused on research related to tobacco regulatory science or tobacco control. Abstracts will be evaluated on the basis of scientific merit. Please send submissions (including title, authors, affiliations, and 250-word abstract) to Diann Gaalema at diann.gaalema@med.uvm.edu by August 15. 

For conference program, registration and hotel links, please visit our conference webpage.

Can't attend the conference? Watch it LIVE at: https://livestream.com/VCBH/Conference2019 

[#DIV28SUPER] POST-DOC in Behavioral Pharmacology (Available Immediately)

Please share with potential applicants and colleagues...

POST-DOC: Preclinical Models of Drug Use & Addiction

Post-doctoral position now available in the Behavioral Neuropharmacology Laboratory at the University of Nebraska-Lincoln. Ongoing research uses standard and novel rat models to study the behavioral, pharmacological, and neural processes mediating the effects of abused drugs. Specific projects include sex differences in meth and nicotine self-administration, drug stimuli and acquired incentive-motivation, treatment of neuroinflammation and the role of exosomes, and behavioral economics of nicotine enhancement of reinforcers including alcohol. We are looking for an individual to join our research team and bring an infusion of new ideas and contribute significantly to the progress of ongoing projects that includes writing manuscripts. Candidates must have a Ph.D. or equivalent degree in related area. Salary will be competitive. Send CV and the name of 3 references electronically to Dr. Rick Bevins at rbevins1@unl.edu. The University of Nebraska is committed to a pluralistic campus community through affirmative action and equal opportunity. We assure reasonable accommodation under the Americans with Disabilities Act.

[#DIV28SUPER] Fwd: APA Interdisciplinary Summit on the Opioid Crisis: Addressing Racial, Ethnic and Socioeconomic Disparities

Dear Division 28 APA colleagues,

If you are interested in being the Division 28 representative for the summit below on racial, ethnic and socioeconomic disparities in the opioid crisis, please send me your CV and a note about your interest as soon as possible. Please send directly to me rather than the list.

Best regards,

Matt

---------- Forwarded message ---------
From: DiGilio, Deborah <Ddigilio@apa.org>
Date: Wed, Jun 19, 2019 at 2:41 PM
Subject: APA Interdisciplinary Summit on the Opioid Crisis: Addressing Racial, Ethnic and Socioeconomic Disparities
To: Matthew Johnson <mwj@jhu.edu>

June 19, 2019

Dear Dr. Johnson:

The American Psychological Association Minority Fellowship Program is hosting a summit, "Interdisciplinary Summit on the Opioid Crisis: Addressing Racial, Ethnic and Socioeconomic Disparities."  The one-day summit will be held in the fall of 2019 in Washington, DC and is the first phase of a project to address the opioid crisis for underserved populations.

The goal is to use an interdisciplinary approach to bring stakeholders together to provide clarity on the history and current state of the opioid crisis for racial and ethnic minorities and low SES populations.  Participants will be expected to:

• Participate in a panel and/or assigned work group
• Collaborate with work group members to create a schedule for follow up meetings
• Agree to a commitment of up to 1 year to complete work group activities

Based on the relevance of Division 28 to this effort, we would like to know if you are interested in sending a representative to participate in the Opioid Summit and lend their expertise to the Training/Education panel/workgroup. We will send a formal invitation to the representative that you name with more details when we receive confirmation of your division's interest in participating.  If you are interested, please respond to Alex Watt at awatt@apa.org with the name, email and telephone number of your representative at your earliest convenience.  

 

We look forward to hearing from you, thank you.

 

Janice Haskins

Clinical Program Manager

Minority Fellowship Program, Public Interest

American Psychological Association

750 First Street NE, Washington DC 20002-4242

202-336-5981 O

--

Matthew W. Johnson, Ph.D.

Google Scholar: https://scholar.google.com/citations?user=fWhYUvwAAAAJ&hl=en
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD  21224-6823
Tel: 410-550-0056
Fax: 410-550-0030
Email: mwj@jhu.edu

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Speaking of Psychology: How Psychologists Can Do More to Address the Opioid Crisis

https://www.apa.org/research/action/speaking-of-psychology/opioid-crisis


Sent from my iPhone

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Postdoctoral Associate Addiction Recovery Research Center Fralin Biomedical Research Institute at VTC

Postdoctoral Associate

Addiction Recovery Research Center

Fralin Biomedical Research Institute at VTC

Imagine working in a stimulating environment where you will be a part of cutting-edge research discoveries where

• multiple NIH grants fund a variety of diverse interdisciplinary and translational research projects 
• invaluable grant-writing experience is gained and encouraged
• you will work closely with some of the leading researchers in addiction and behavioral economics
• you are encouraged to pitch your own ideas for meaningful research projects that fall within the scope of the lab 
• postdoctoral associates average 5 published manuscripts per year
  
  

Imagine a growing research institute that attracts leading scientists from across the nation -- The Fralin Biomedical Research Institute at VTC (formerly known as the Virginia Tech Carilion Research Institute) is a unique public-private partnership that leverages Virginia Tech's world-class strength in basic sciences, bioinformatics, and engineering with Carilion Clinic's highly experienced medical staff and a rich history in medical education. Virginia Tech Carilion (VTC) improves human health and quality of life by providing leadership in medical education and biomedical and clinical research.  This academic health center was recently renamed Fralin Biomedical Research Institute at VTC in honor of the $50 million donation provided by the generosity of Heywood and Cynthia Fralin to progress the growth of this institute and its contributions to medical and research advancements.

Position Summary:  The Addiction Recovery Research Center (ARRC) is directed by Dr. Warren K. Bickel, an accomplished scholar and researcher whose work is frequently cited and receives national and international recognition. This position will work primarily on NIH funded projects that are providing new information about substance and alcohol use disorders, health behaviors, and decision-making. Several projects are focusing on the use of the Experimental Tobacco Marketplace to investigate choice behavior among nicotine users from a behavioral economics framework. Other projects are focusing on treatments for opioid use disorder and the examination of Episodic Future Thinking to improve health in individuals with prediabetes and other lifestyle related disorders. Moreover, ARRC has ongoing projects to examine the effects of Transcranial Magnetic Stimulation on cigarette smoking and overeating. The position is well suited for individuals interested in technological and behavioral economic applications to addiction and health behavior. This postdoctoral position will also be involved in developing pilot research programs in the research areas of the lab and will be expected to help develop these additional projects.

Appointment:  1-3 yrs.

 

Eligibility: Candidates are expected to have a solid background in psychology, behavioral economics, and/or addiction or health behaviors research. In addition, experience with behavior analysis and/or clinical trials is highly desirable. The successful candidate will possess a PhD in psychology, neuroscience, or appropriate related discipline and have a record of research excellence as indicated by peer-reviewed publications and presentations.  

Benefits: Full-time annual salary, medical insurance coverage, and travel funds supported by NIH grants. Translational research training and career development opportunities are provided as part of this position.

 

For more information:  Contact Ms. Patsy Marshall (patsym@vtc.vt.edu).

 

To apply: Send cover letter, curriculum vitae, and a statement of research interests to:  Dr. Warren K. Bickel c/o Ms. Patsy Marshall (patsym@vtc.vt.edu). Applications will be reviewed on an ongoing basis.

 

About us: The Addiction Recovery Research Center (ARRC) was established in 2011 as part of the Virginia Tech Carilion Research Institute (VTCRI). The existing facilities and research teams are world-class and focus on transdisciplinary research on the scientific underpinnings of health and a range of diseases and substance use disorders. A new biomedical expansion is currently being constructed and will include additional research laboratories to focus on brain health and disorders, biomaterials-body device interfaces, cardiovascular sciences, cancer, metabolism and obesity, and infectious disease and immunity. The Fralin Biomedical Research Institute at VTC represents a new model for biomedical and behavioral science in which creative scientists can approach major problems with breadth and depth in a nurturing and intellectually challenging environment.

About Roanoke, Virginia: Roanoke, Virginia is located in Southwest Virginia in the foothills of the Appalachian Mountains and accessible by the Blue Ridge Parkway. Roanoke is a vibrant community with an active downtown full of restaurants, theaters, museums, and an amphitheater that is home to many seasonal festivals and music events. Roanoke also offers great opportunities for an active outdoor lifestyle with 30 miles of greenway connecting charming neighborhoods and beautiful parks along the Roanoke River. Roanoke is one of two cities in the nation to earn the All-American City Award a record seven times.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Interim Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Dr Kreek suggests higher age limit on legalization

https://www.nytimes.com/2019/06/16/opinion/marijuana-brain-effects.html?smid=nytcore-ios-share


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] UNIVERSITY OF VERMONT NIH POSTDOCTORAL RESEARCH FELLOWSHIP OPPORTUNITY

UNIVERSITY OF VERMONT, CENTER ON BEHAVIOR AND HEALTH

POSTDOCTORAL RESEARCH FELLOWSHIP

 

The University of Vermont's Center on Behavior and Health announces a NIH postdoctoral research fellowship opportunity in our internationally recognized center of excellence for the study of substance abuse. The fellow will participate in the conduct of ongoing NIDA trial aimed at evaluating low-barrier, technology-assisted buprenorphine treatment for individuals with opioid use disorder (Dr. Stacey Sigmon) and develop new research opportunities in related areas. The mentoring team has an exceptional track record of helping fellows further their careers as independent investigators.

 

Eligibility: Applicants must have completed their training in psychology or a related discipline and be U.S. citizens or permanent residents. Trainees are selected on the basis of scholastic record and commitment to a career in drug abuse research. Individuals must be highly motivated, possess initiative and a desire to learn and expand their interests and expertise.

 

Appointment: 2-3 yrs.

 

Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

 

To apply: Send application form (downloaded from VCBH website), a cover letter, curriculum vitae, statement of research interests, and 3 letters of reference to: Dr. Stacey Sigmon c/o Ms. Marissa Palmer (marissa.palmer@uvm.edu).

 

About us: The VCBH was established in 2013, sponsored in part by a Centers of Biomedical Research Excellence (COBRE) Award from the National Institute on General Medical Sciences and a Centers of Tobacco Regulatory Science (TCORS) Award from the National Institute on Drug Abuse. The VCBH resides within the College of Medicine at the University of Vermont, with the director and administrative offices being located within the Department of Psychiatry, and participating investigators, collaborators, and advisors across 15 academic departments in the College of Medicine and 7 colleges within UVM and 5 other universities. The VCBH is further strengthened by interdisciplinary collaborations with key community healthcare leaders and distinguished scientific advisory panels. The focus of the VCBH is on investigating relationships between personal behaviors and risk for chronic disease and premature death, with a specific focus on understanding mechanisms underpinning risk, and developing effective interventions and policies to promote healthy behavior.

 

For more information: Contact Ms. Marissa Palmer, marissa.palmer@uvm.edu or see our website.

 

Burlington, Vermont is located in the beautiful Lake Champlain region, surrounded by the Green and Adirondack Mountains. It is a great place for families, boasting excellent schools and year-round recreational opportunities. It is home to the University of Vermont and many other colleges that provide an academically stimulating and culturally rich environment. Montreal and Boston are within easy driving distances.

--

Stephen T. Higgins, Ph.D.

Director, Vermont Center for Behavior and Health

Professor and Virginia H. Donaldson Chair in Translational Science, Departments of Psychiatry and Psychological Science

University of Vermont

1 South Prospect Street

Burlington, VT  05401-1419

[#DIV28SUPER] Postdoc in Translational Science of Alcohol and HIV at the University of Florida

UNIVERSITY OF FLORIDA -

TRANSLATIONAL SCIENCE TRAINING TO REDUCE THE

IMPACT OF ALCOHOL ON HIV INFECTION

 

OPENING FOR POSTDOCTORAL FELLOW IN T32 TRAINING PROGRAM

 

Multidisciplinary training program focused on alcohol and HIV

Behavioral and clinical interventions

Data science

Neurocognition and brain science

 

Postdocs will work on NIH-funded grants, participate in seminars and training programs,

develop their own research programs and be mentored by outstanding faculty including

Co-Directors Drs. Robert Cook, Robert Leeman and Robert Lucero and colleagues from the following disciplines:  

Biostatistics: Drs. Babette Brumback

Clinical & Health Psychology: Drs. Ron Cohen, Eric Porges, Catherine Price, Adam Woods

Epidemiology: Drs. Xinguang Chen, Linda Cottler, Mattia Prosperi

Health Education & Behavior: Drs. JeeWon Cheong, Jalie Tucker

Nursing: Drs. Anna McDaniel, Diana Wilkie

Pathology: Dr. Marco Salemi

Psychiatry/Psychology: Dr. Sara Jo Nixon

 

Funding includes an annual stipend, research/travel expenses and health insurance

Individuals from under represented populations are strongly encouraged to apply

 

Email questions & CV to:

sharct32@phhp.ufl.edu

 

For more information:

http://ufl.to/to

 

[#DIV28SUPER] Postdoctoral Associate Addiction Recovery Research Center Fralin Biomedical Research Institute

Postdoctoral Associate

Addiction Recovery Research Center

Fralin Biomedical Research Institute

Imagine working in a stimulating environment where you will be a part of cutting-edge research discoveries where

• multiple NIH grants fund a variety of diverse interdisciplinary and translational research projects 
• invaluable grant-writing experience is gained and encouraged
• you will work closely with some of the leading researchers in addiction and behavioral economics
• you are encouraged to pitch your own ideas for meaningful research projects that fall within the scope of the lab 
• postdoctoral associates average 5 published manuscripts per year
  
  

Imagine a growing research institute that attracts leading scientists from across the nation -- The Fralin Biomedical Research Institute at VTC (formerly known as the Virginia Tech Carilion Research Institute) is a unique public-private partnership that leverages Virginia Tech's world-class strength in basic sciences, bioinformatics, and engineering with Carilion Clinic's highly experienced medical staff and a rich history in medical education. Virginia Tech Carilion (VTC) improves human health and quality of life by providing leadership in medical education and biomedical and clinical research.  This academic health center was recently renamed Fralin Biomedical Research Institute at VTC in honor of the $50 million donation provided by the generosity of Heywood and Cynthia Fralin to progress the growth of this institute and its contributions to medical and research advancements.

Position Summary:  The Addiction Recovery Research Center (ARRC) is directed by Dr. Warren K. Bickel, an accomplished scholar and researcher whose work is frequently cited and receives national and international recognition. This position will work primarily on NIH funded projects that are providing new information about substance and alcohol use disorders, health behaviors, and decision-making. Several projects are focusing on the use of the Experimental Tobacco Marketplace to investigate choice behavior among nicotine users from a behavioral economics framework. Other projects are focusing on treatments for opioid use disorder and the examination of Episodic Future Thinking to improve health in individuals with prediabetes and other lifestyle related disorders. Moreover, ARRC has ongoing projects to examine the effects of Transcranial Magnetic Stimulation on cigarette smoking and overeating. The position is well suited for individuals interested in technological and behavioral economic applications to addiction and health behavior. This postdoctoral position will also be involved in developing pilot research programs in the research areas of the lab and will be expected to help develop these additional projects.

Appointment:  1-3 yrs.

 

Eligibility: Candidates are expected to have a solid background in psychology, behavioral economics, and/or addiction or health behaviors research. In addition, experience with behavior analysis and/or clinical trials is highly desirable. The successful candidate will possess a PhD in psychology, neuroscience, or appropriate related discipline and have a record of research excellence as indicated by peer-reviewed publications and presentations.  

Benefits: Full-time annual salary, medical insurance coverage, and travel funds supported by NIH grants. Translational research training and career development opportunities are provided as part of this position.

 

For more information:  Contact Ms. Patsy Marshall (patsym@vtc.vt.edu).

 

To apply: Send cover letter, curriculum vitae, and a statement of research interests to:  Dr. Warren K. Bickel c/o Ms. Patsy Marshall (patsym@vtc.vt.edu). Applications will be reviewed on an ongoing basis.

 

About us: The Addiction Recovery Research Center (ARRC) was established in 2011 as part of the Virginia Tech Carilion Research Institute (VTCRI). The existing facilities and research teams are world-class and focus on transdisciplinary research on the scientific underpinnings of health and a range of diseases and substance use disorders. A new biomedical expansion is currently being constructed and will include additional research laboratories to focus on brain health and disorders, biomaterials-body device interfaces, cardiovascular sciences, cancer, metabolism and obesity, and infectious disease and immunity. The Fralin Biomedical Research Institute at VTC represents a new model for biomedical and behavioral science in which creative scientists can approach major problems with breadth and depth in a nurturing and intellectually challenging environment.

About Roanoke, Virginia: Roanoke, Virginia is located in Southwest Virginia in the foothills of the Appalachian Mountains and accessible by the Blue Ridge Parkway. Roanoke is a vibrant community with an active downtown full of restaurants, theaters, museums, and an amphitheater that is home to many seasonal festivals and music events. Roanoke also offers great opportunities for an active outdoor lifestyle with 30 miles of greenway connecting charming neighborhoods and beautiful parks along the Roanoke River. Roanoke is one of two cities in the nation to earn the All-American City Award a record seven times.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Interim Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] James Ketchum, Who Conducted LSD Experiments on Soldiers, Dies at 87

https://www.nytimes.com/2019/06/03/obituaries/james-ketchum-dead.html?smid=nytcore-ios-share


Sent from my iPhone
_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Experimental and Clinical Psychopharmacology Special Issue

Call for Papers: Experimental and Clinical Psychopharmacology

Special Issue for April 2020 on:

Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability in Substance Use Disorders

This special issue will provide an overview of current translational research from both human and nonhuman animal researchers investigating individual difference factors in vulnerability to drug and alcohol use disorders. The goal of this special issue is to highlight translational clinical and preclinical research and to catalyze future translational approaches in the field. We encourage submission of review articles and original research reports in these areas, including individual difference factors in environmental, trait, and/or genetic domains. We encourage research that is translational in nature and would be especially interested in paired-research articles from different laboratories that are investigating the same individual difference factors across clinical and preclinical models. If submitting paired articles, authors are also invited to submit a comment on that set of articles. Nonhuman animal research that is translatable to the human conditions and human research that can be back translated to a nonhuman model are preferred. Papers addressing a variety of substances, including alcohol, marijuana, stimulants, and opiates, and their disorders, are welcome.

Researchers in this area may submit review articles or primary research reports to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (http://pha.edmgr.com/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on Advancing the Translation Between Clinical and Preclinical Models of Individual Differences in Vulnerability to Substance Use Disorders.  All submissions will undergo our normal peer review. Manuscripts received no later than October 1, 2019 will be considered for inclusion in the special issue. We strongly encourage individuals to contact the guest editors in advance with their ideas and a draft of the title and abstract.

Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, Melissa A. Cyders, PhD, at mcyders@iu.edu or Dustin J. Stairs, PhD, at dustinstairs@creighton.edu, or the Editor, William W. Stoops, PhD at william.stoops@uky.edu.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science

Interim Director

Clinical Research Support Office

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.